Citadel Advisors »

Salarius Pharmaceuticals shares owned by Citadel Advisors

Quarter-by-quarter ownership of Salarius Pharmaceuticals (SLRX) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Salarius Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Salarius Pharmaceuticals held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Salarius Pharmaceuticals by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $16k 25k 0.64

More positions owned by Citadel Advisors

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Tesla Motors Call Option (TSLA)
NVIDIA Corporation Call Option (NVDA)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Microsoft Corporation Call Option (MSFT)
Meta Platforms Cl A Call Option (META)
Apple Call Option (AAPL)
Amazon Call Option (AMZN)
Ishares Tr Iboxx Hi Yd Etf Call Option (HYG)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Advanced Micro Devices Call Option (AMD)
Netflix Call Option (NFLX)
Alphabet Cap Stk Cl C Call Option (GOOG)
Booking Holdings Call Option (BKNG)

View all positions for Citadel Advisors

Top funds holding Salarius Pharmaceuticals

Horizon Kinetics Asset Management
Citadel Advisors
Vanguard Group
Two Sigma Securities
Advisor Group Holdings
UBS Group
Wells Fargo & Company
Bank of America Corporation

View all funds holding Salarius Pharmaceuticals